Liraglutide
Jump to navigation
Jump to search
![]() NMR structure of liraglutide. PDB entry 4apd | |
Clinical data | |
---|---|
Trade names | Victoza, Saxenda |
License data | |
Pregnancy category | |
Routes of administration | subcutaneous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
ECHA InfoCard | 100.241.015 ![]() |
Chemical and physical data | |
Formula | C172H265N43O51 |
Molar mass | 3751.202 g/mol |
3D model (JSmol) | |
| |
|
Liraglutide (marketed with brand name Victoza) is a Type 2 diabetes medication. It is a long-acting glucagon like peptide-1 agonist. It was approved by the Food and Drug Administration in early 2010.
This medication is a once daily treatment of Type 2 diabetes.